Virginia Commonwealth University (VCU) seeks funding for an Institutional Clinical and Translational Science Awiard (CTSA). This opportunity comes at a pivotal phase in VCU's growth and development as a premier biomedical research institution and coincides with significant institutional commitment and direction recommended by the Board of Visitors. To accomplish the goals of the CTSA initiative, VCU has established a comprehensive matrix center, the Center for Clinical and Translational Research (CCTR). The CCTR willfacilitate the development of new partnerships and new initiatives that will extend our research base of federal, private, and industry sponsored awards. Our already strong research program will be encouraged and abetted by a cultural transformation to support translational science and an influx of newly recruited multi-disciplinary investigators. The CCTR leverages substantial existing resources to encourage and support novel research methodologies at VCU. Emphasis is placed on three areas of research strength; namely substance abuse, women's health and rehabilitation science. Pilot funds will be awarded to support innovation and community engagement research in these areas. Architecture for a Clinical and Translational Data Environment, an enterprise data warehouse, and a collaborative web portal to facilitate data sharing across VCU, VCU Health System (VCUHS), other CTSA sites and national research networks has been developed A Research Incubator provides biostatistical support, facilitates research, encourages research in research ethics and provides guidance in regulatory issues. Strategies to enhance research subject participation, facilities for the conduction of human research, and access to the IVIid-Atlantic Twin Registry are described. Centralized management of and access to a rich array of research resources will be accomplished through the CCTR. Our students will enroll in trans-disciplinary educational cumcula which encourage team building including both a MS and a PhD in Clinical and Translational Science. CCTR will strengthen ties with our affiliates and community partners to make better use of their unique resources and respond to their needs.
Effective delivery of research which moves from the bench to the bedside to the community requires a transformation of research practice at every level. The present grant will support the efforts of VCU to strengthen ties with our affiliates and community partners to make better use of their unique resources and respond to their needs.
|Dusing, Stacey C; Thacker, Leroy R; Galloway, James C (2016) Infant born preterm have delayed development of adaptive postural control in the first 5 months of life. Infant Behav Dev 44:49-58|
|Abbate, Antonio; Kontos, Michael Christopher; Abouzaki, Nayef Antar et al. (2015) Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies). Am J Cardiol 115:288-92|
|Coe, Antoinette B; Moczygemba, Leticia R; Gatewood, Sharon B S et al. (2015) Medication adherence challenges among patients experiencing homelessness in a behavioral health clinic. Res Social Adm Pharm 11:e110-20|
|Evangelou, Iordanis E; Massoud, Raya; Jacobson, Steven (2014) HTLV-I-associated myelopathy/tropical spastic paraparesis: semiautomatic quantification of spinal cord atrophy from 3-dimensional MR images. J Neuroimaging 24:74-8|
|Sonnino, Chiara; Christopher, Sanah; Oddi, Claudia et al. (2014) Leukocyte activity in patients with ST-segment elevation acute myocardial infarction treated with anakinra. Mol Med 20:486-9|
|Van Tassell, Benjamin Wallace; Arena, Ross; Biondi-Zoccai, Giuseppe et al. (2014) Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study). Am J Cardiol 113:321-327|
|Falcao, Raquel Appa; Christopher, Sanah; Oddi, Claudia et al. (2014) Interleukin-10 in patients with ST-segment elevation myocardial infarction. Int J Cardiol 172:e6-8|
|Vecile, Elena; Dobrina, Aldo; Salloum, Fadi N et al. (2013) Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes. PLoS One 8:e53265|
|Abbate, Antonio; Van Tassell, Benjamin Wallace; Biondi-Zoccai, Giuseppe et al. (2013) Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study]. Am J Cardiol 111:1394-400|
|Ohayon, Joan; Oh, Unsong; Richert, Nancy et al. (2013) CNS vasculitis in a patient with MS on daclizumab monotherapy. Neurology 80:453-7|
Showing the most recent 10 out of 31 publications